130
Participants
Start Date
May 15, 2018
Primary Completion Date
May 30, 2026
Study Completion Date
May 30, 2027
PSMA -PET/CT simulation
"* PET/CT simulation.~* If no additional lesions detected: RT as planned per standard care.~* If PSMA-PET/CT imaging consistent with oligometastases (1-5 lesions): all lesions must be treated with definitive RT.~* If PSMA-PET/CT imaging consistent with widely metastatic disease (\>5 lesions): treatment of all detected disease with RT is not recommended, but treatment of the primary site as initially planned is encouraged."
Standard-care simulation
No PSMA-PET/CT as part of RT treatment planning.
CSSSL - Cité de la Santé Laval, Laval
Centre Hospitalier de l'Université de Montréal, Montreal
CHU de Québec, Québec
Progenics Pharmaceuticals, Inc.
INDUSTRY
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER